Description

Antiviral effectiveness of the EAM-ESN blend against A/H1N1 and HCoV-OC43 is depicted across multiple concentrations. The results indicate significant viral load reduction at higher blend concentrations.

Figure 8

Chart

Source Paper

Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) …

Pharmaceuticals (Basel, Switzerland) (2022)

PMID: 35631445

DOI: 10.3390/ph15050619

Cite This Figure

![Figure 8: Antiviral effectiveness of the EAM-ESN blend against A/H1N1 and HCoV-OC43 is depicted across multiple concentrations. The results indicate significant viral load reduction at higher blend concentrations.]()

> Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." *Pharmaceuticals (Basel, Switzerland)*, 2022. PMID: [35631445](https://pubmed.ncbi.nlm.nih.gov/35631445/)

<figure>
  <img src="" alt="Antiviral effectiveness of the EAM-ESN blend against A/H1N1 and HCoV-OC43 is depicted across multiple concentrations. The results indicate significant viral load reduction at higher blend concentrations." />
  <figcaption>Figure 8. Antiviral effectiveness of the EAM-ESN blend against A/H1N1 and HCoV-OC43 is depicted across multiple concentrations. The results indicate significant viral load reduction at higher blend concentrations.<br>  Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631445/">35631445</a></figcaption>
</figure>

Related Evidence

Elderberry for Influenza

Grade B · 5 studies